Inside of a current review, we noted the identification and also the characterization of a new atypical opioid receptor with exceptional unfavorable regulatory Houses in direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is additionally